We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
China has eased its drug regulations in hopes of drawing some of the new meds for which its citizens are clamoring. Swiss CDMO Lonza is joining a rush of companies looking to cash in on the situation by establishing its firs.